DE69528602T2 - Prophylaktische behandlung der allergischen kontaktdermatitis - Google Patents

Prophylaktische behandlung der allergischen kontaktdermatitis

Info

Publication number
DE69528602T2
DE69528602T2 DE69528602T DE69528602T DE69528602T2 DE 69528602 T2 DE69528602 T2 DE 69528602T2 DE 69528602 T DE69528602 T DE 69528602T DE 69528602 T DE69528602 T DE 69528602T DE 69528602 T2 DE69528602 T2 DE 69528602T2
Authority
DE
Germany
Prior art keywords
prophylactic treatment
contact dermatitis
allergic contact
skin
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69528602T
Other languages
English (en)
Other versions
DE69528602D1 (de
Inventor
J Wille
Agis Kydonieus
S Castellana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE69528602D1 publication Critical patent/DE69528602D1/de
Publication of DE69528602T2 publication Critical patent/DE69528602T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69528602T 1994-11-22 1995-11-15 Prophylaktische behandlung der allergischen kontaktdermatitis Expired - Fee Related DE69528602T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/343,157 US5618557A (en) 1994-11-22 1994-11-22 Prophylactic treatment of allergic contact dermatitis
PCT/US1995/014918 WO1996015669A1 (en) 1994-11-22 1995-11-15 Prophylactic treatment of allergic contact dermatitis

Publications (2)

Publication Number Publication Date
DE69528602D1 DE69528602D1 (de) 2002-11-21
DE69528602T2 true DE69528602T2 (de) 2003-06-26

Family

ID=23344937

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528602T Expired - Fee Related DE69528602T2 (de) 1994-11-22 1995-11-15 Prophylaktische behandlung der allergischen kontaktdermatitis

Country Status (10)

Country Link
US (1) US5618557A (de)
EP (1) EP0802731B1 (de)
JP (1) JPH10512850A (de)
AT (1) ATE226014T1 (de)
AU (1) AU695804B2 (de)
CA (1) CA2205920A1 (de)
DE (1) DE69528602T2 (de)
MX (1) MX9703693A (de)
NZ (1) NZ296892A (de)
WO (1) WO1996015669A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
EP1802258A4 (de) 2004-09-13 2015-09-23 Chrono Therapeutics Inc Biosynchrone transdermale arzneiabgabe
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US20070042026A1 (en) * 2005-03-17 2007-02-22 Wille John J Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
WO2007084464A2 (en) * 2006-01-17 2007-07-26 The University Of North Carolina At Chapel Hill Water channel blockers and methods of use thereof
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
KR20150095870A (ko) 2012-12-17 2015-08-21 패리온 사이언스 인코퍼레이티드 3,5-디아미노-6-클로로-n-(n-(4-페닐부틸)카르밤이미도일)피라진-2-카르복스아미드 화합물
DK2931713T3 (en) 2012-12-17 2017-01-30 Parion Sciences Inc CHLORPYRAZINE CARBOXAMIDE DERIVATIVES USED FOR THE TREATMENT OF DISEASES BENEFITED BY INDEPENDENT MOSPHEREWIN
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
CA2977814A1 (en) 2015-03-12 2016-09-15 Chrono Therapeutics Inc. Craving input and support system
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
EP3801732A4 (de) 2018-05-29 2022-04-27 Morningside Venture Investments Limited Verfahren und systeme zur wirkstofffreisetzung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968245A (en) * 1973-10-12 1976-07-06 Alza Corporation Sympathomimetic topical and percutaneous administration with halogenated promoters
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4888354A (en) * 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
WO1990009792A1 (en) * 1989-03-03 1990-09-07 The General Hospital Corporation Topical application of amiloride or analogues thereof for treatment of inflammation
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs

Also Published As

Publication number Publication date
EP0802731A1 (de) 1997-10-29
WO1996015669A1 (en) 1996-05-30
AU4162896A (en) 1996-06-17
NZ296892A (en) 1998-04-27
EP0802731B1 (de) 2002-10-16
JPH10512850A (ja) 1998-12-08
MX9703693A (es) 1998-02-28
ATE226014T1 (de) 2002-11-15
US5618557A (en) 1997-04-08
AU695804B2 (en) 1998-08-20
DE69528602D1 (de) 2002-11-21
CA2205920A1 (en) 1996-05-30
EP0802731A4 (de) 1999-08-04

Similar Documents

Publication Publication Date Title
DE69528602T2 (de) Prophylaktische behandlung der allergischen kontaktdermatitis
DE69529577D1 (de) Prophylaktische und therapeutische behandlung von haupt sensibilisierung und -reizung
PT880350E (pt) Tratamento de esclerose multipla
NO981392L (no) Substituerte pyrazolylbenzensulfonamider for anvendelse i veterinµrterapi som antiinflammatorisk middel
ATE125445T1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
ATE59547T1 (de) Mittel zum reduzieren der ausbreitung des sebums.
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
ATE231837T1 (de) Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung
NZ333324A (en) Prophylactic treatment of skin sensitization and irritation
SE9502893D0 (sv) Användning av kollagenas
DE68912195T2 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DK261490D0 (da) New pharmaceutical compound
ATE40946T1 (de) Arzneimittel oder prophylaktisches mittel zur behandlung von epilepsie.
JPS5218813A (en) Plasters for the relief of cutaneous diseases
ATE215810T1 (de) Abschuppungs-zusammensetzung
ATE273713T1 (de) Fas-antagonist für die prophylaxe oder therapie von gvhd
ATE335501T1 (de) Mittel zur behandlung von allergischen oder überempfindlichkeitszuständen
ATE130515T1 (de) Mittel zur topischen verabreichung von spironolakton.
ES2125356T3 (es) Empleo de leflunomida para la inhibicion de interleuquina 8.
ES2187836T3 (es) Utilizacion de un extracto de terminalia catappa.
NO984245D0 (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse
EP0693479A4 (de) Neue aconitin ähnliche verbindung und antipyretisches, analgetisches und entzündungshemmendes mittel
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
NO995539L (no) Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av cerebrale ödemer
JPS52131653A (en) Rinse type gas treatment device

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee